id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0610-0016,FDA,FDA-2008-D-0610,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2018-06-19T04:00:00Z,2018,6,2018-06-19T04:00:00Z,,2018-06-19T18:46:08Z,2018-13098,0,0,090000648342f63c
FDA-2008-D-0610-0015,FDA,FDA-2008-D-0610,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Postmarketing Adverse Event Reporting for Medical Products
and Dietary Supplements During an Influenza Pandemic",Notice,30 Day Proposed Information Collection,2018-04-09T04:00:00Z,2018,4,2018-04-09T04:00:00Z,2018-05-10T03:59:59Z,2018-04-09T15:36:56Z,2018-07154,0,0,09000064830dd395